home All News open_in_new Full Article

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced achievement of a $14 million cash research milestone from GSK associated with a […]


today 7 h. ago attach_file Economics

attach_file Economics
attach_file Culture
attach_file Other
attach_file Politics
attach_file Economics
attach_file Other
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Science
attach_file Economics
attach_file Economics
attach_file Events
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Culture


ID: 3244565301
Add Watch Country

arrow_drop_down